Literature DB >> 34623872

Reply to K. Takada et al.

Noha Sharafeldin1, Benjamin Bates1, Qianqian Song1, Vithal Madhira1, Yu Raymond Shao1, Feifan Liu1, Timothy Bergquist1, Jing Su1, Umit Topaloglu1.   

Abstract

Entities:  

Year:  2021        PMID： 34623872      PMCID： PMC8659995          DOI： 10.1200/JCO.21.02150

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes.

Authors:  Kazuki Takada; Shinkichi Takamori; Naoko Miura; Yasunori Shikada; Mototsugu Shimokawa
Journal:  J Clin Oncol       Date:  2021-10-08       Impact factor: 44.544

2.  Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer.

Authors:  Cynthia Villarreal-Garza; Bryan F Vaca-Cartagena; Andrea Becerril-Gaitan; Ana S Ferrigno; Fernanda Mesa-Chavez; Alejandra Platas; Ana Platas
Journal:  JAMA Oncol       Date:  2021-08-01       Impact factor: 33.006

3.  Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).

Authors:  Noha Sharafeldin; Benjamin Bates; Qianqian Song; Vithal Madhira; Yao Yan; Sharlene Dong; Eileen Lee; Nathaniel Kuhrt; Yu Raymond Shao; Feifan Liu; Timothy Bergquist; Justin Guinney; Jing Su; Umit Topaloglu
Journal:  J Clin Oncol       Date:  2021-06-04       Impact factor: 50.717

4.  Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Authors:  Leticia Monin; Adam G Laing; Miguel Muñoz-Ruiz; Duncan R McKenzie; Irene Del Molino Del Barrio; Thanussuyah Alaguthurai; Clara Domingo-Vila; Thomas S Hayday; Carl Graham; Jeffrey Seow; Sultan Abdul-Jawad; Shraddha Kamdar; Elizabeth Harvey-Jones; Rosalind Graham; Jack Cooper; Muhammad Khan; Jennifer Vidler; Helen Kakkassery; Shubhankar Sinha; Richard Davis; Liane Dupont; Isaac Francos Quijorna; Charlotte O'Brien-Gore; Puay Ling Lee; Josephine Eum; Maria Conde Poole; Magdalene Joseph; Daniel Davies; Yin Wu; Angela Swampillai; Bernard V North; Ana Montes; Mark Harries; Anne Rigg; James Spicer; Michael H Malim; Paul Fields; Piers Patten; Francesca Di Rosa; Sophie Papa; Timothy Tree; Katie J Doores; Adrian C Hayday; Sheeba Irshad
Journal:  Lancet Oncol       Date:  2021-04-27       Impact factor: 41.316

5.  COVID-19 vaccine race: watch your step for cancer patients.

Authors:  Raphaelle Fanciullino; Joseph Ciccolini; Gerard Milano
Journal:  Br J Cancer       Date:  2020-12-07       Impact factor: 7.640

6.  The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.

Authors:  Melissa A Haendel; Christopher G Chute; Tellen D Bennett; David A Eichmann; Justin Guinney; Warren A Kibbe; Philip R O Payne; Emily R Pfaff; Peter N Robinson; Joel H Saltz; Heidi Spratt; Christine Suver; John Wilbanks; Adam B Wilcox; Andrew E Williams; Chunlei Wu; Clair Blacketer; Robert L Bradford; James J Cimino; Marshall Clark; Evan W Colmenares; Patricia A Francis; Davera Gabriel; Alexis Graves; Raju Hemadri; Stephanie S Hong; George Hripscak; Dazhi Jiao; Jeffrey G Klann; Kristin Kostka; Adam M Lee; Harold P Lehmann; Lora Lingrey; Robert T Miller; Michele Morris; Shawn N Murphy; Karthik Natarajan; Matvey B Palchuk; Usman Sheikh; Harold Solbrig; Shyam Visweswaran; Anita Walden; Kellie M Walters; Griffin M Weber; Xiaohan Tanner Zhang; Richard L Zhu; Benjamin Amor; Andrew T Girvin; Amin Manna; Nabeel Qureshi; Michael G Kurilla; Sam G Michael; Lili M Portilla; Joni L Rutter; Christopher P Austin; Ken R Gersing
Journal:  J Am Med Inform Assoc       Date:  2021-03-01       Impact factor: 7.942
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.